"10.1371_journal.pone.0053050","plos one","2012-12-31T00:00:00Z","Gwendlyn Kollmorgen; Birgit Bossenmaier; Gerhard Niederfellner; Hans-Ulrich Häring; Reiner Lammers","Pharma Research and Early Development, Roche Diagnostics GmbH, Penzberg, Germany; Department of Internal Medicine IV, University of Tübingen, Tübingen, Germany","Conceived and designed the experiments: BB HH RL. Performed the experiments: GK GN RL. Analyzed the data: GK BB RL. Contributed reagents/materials/analysis tools: GN RL. Wrote the paper: GK BB RL.","G. Kollmorgen, B. Bossenmaier, and G. Niederfellner are employees of Roche Diagnostics. Roche Diagnostics supported the study by a grant to R. Lammers. R. Lammers shares a patent on CDCP1-specific CUB-antibodies (including CUB1 used in this study) that was licensed to Roche Diagnostics. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2012","12","Gwendlyn Kollmorgen","GK",5,TRUE,3,3,3,3,TRUE,TRUE,FALSE,0,NA,FALSE
